Pathway Genomics is a medical diagnostic company that is working to empower patients as well as physicians with accessibility to tests that will improve overall wellness and specific health outcomes. The company was founded in 2008, and since then it has grown to become a leader in the healthcare industry. The following is a brief history of the company from 2008 until now.
Pathway Genomics was founded by Jim Plante, an investor and leader in medical technology. He was inspired to start the diagnostics company after his father died due to complications from a genetically transmitted form of kidney disease. Knowing that his father’s illness might have been prevented had it been detected earlier sparked Plante’s interest in making more diagnostic testing available to everyone. He served as CEO of Pathway Genomics from 2008 until 2017. Plante is currently the CEO of the biotechnology company Klothotherapeutics.